Proactive vs Reactive Treatment of Hypotension During Surgery: The PRETREAT Randomized Clinical Trial.

JAMA Pub Date : 2025-10-12 DOI:10.1001/jama.2025.18007
Matthijs Kant,Wilton A van Klei,Markus W Hollmann,Eline S de Klerk,Luuk C Otterspoor,Marc G Besselink,Teus H Kappen,Denise P Veelo,
{"title":"Proactive vs Reactive Treatment of Hypotension During Surgery: The PRETREAT Randomized Clinical Trial.","authors":"Matthijs Kant,Wilton A van Klei,Markus W Hollmann,Eline S de Klerk,Luuk C Otterspoor,Marc G Besselink,Teus H Kappen,Denise P Veelo, ","doi":"10.1001/jama.2025.18007","DOIUrl":null,"url":null,"abstract":"Importance\r\nIntraoperative hypotension is associated with adverse postoperative outcomes, but whether a proactive strategy to prevent intraoperative hypotension improves outcomes is uncertain.\r\n\r\nObjective\r\nTo determine whether intraoperative blood pressure management stratified by risk of hypotension reduces postoperative functional disability compared with usual care in adults undergoing noncardiac surgery.\r\n\r\nDesign, Setting, and Participants\r\nIn this randomized clinical trial, adults undergoing elective noncardiac surgery at 2 tertiary hospitals in the Netherlands were enrolled from June 17, 2021, to February 7, 2024. The date of last follow-up was October 24, 2024.\r\n\r\nIntervention\r\nPatients were randomized 1:1 to proactive blood pressure management with mean arterial pressure targets based on risk of intraoperative hypotension (low risk, ≥70 mm Hg; intermediate risk, ≥80; high risk, ≥90) or usual management at their anesthesiologist's discretion, generally aiming to avoid a mean arterial pressure of less than 65 mm Hg without higher predefined targets.\r\n\r\nMain Outcomes and Measures\r\nThe primary outcome was functional disability at 6 months, assessed with the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0; scale range, 0-100; higher scores indicate more disability). A minimally clinically important difference of 5 points was prespecified. There were 23 secondary outcomes, including quality of life, complications, and mortality within 6 months.\r\n\r\nResults\r\nThe trial was stopped early for futility after 3247 of 5000 planned patients (median age, 59 years [IQR, 44-69]; 1738 female [53.5%]) were enrolled. A total of 677 patients (21%) were low risk; 1814 (56%), intermediate risk, and 756 (23%), high risk. Baseline median WHODAS scores were 12.5 [IQR, 4.2-29.2] in proactive group and 14.6 [IQR, 4.2-29.2] in standard group). At 6 months, mean (SD) WHODAS scores were 17.7 (20.1) in the proactive group and 18.2 (20.5) in the standard group (mean difference, -0.5; 95% credible interval, -1.9 to 0.9). There were no significant differences in any of the 23 secondary outcomes.\r\n\r\nConclusions and Relevance\r\nIntraoperative blood pressure management with mean arterial pressure goals stratified by risk of hypotension did not improve functional disability at 6 months postoperatively compared with standard intraoperative blood pressure management.\r\n\r\nTrial Registration\r\nOverview of Medical Research in the Netherlands (CCMO): NL-OMON55117.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"208 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1001/jama.2025.18007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Importance Intraoperative hypotension is associated with adverse postoperative outcomes, but whether a proactive strategy to prevent intraoperative hypotension improves outcomes is uncertain. Objective To determine whether intraoperative blood pressure management stratified by risk of hypotension reduces postoperative functional disability compared with usual care in adults undergoing noncardiac surgery. Design, Setting, and Participants In this randomized clinical trial, adults undergoing elective noncardiac surgery at 2 tertiary hospitals in the Netherlands were enrolled from June 17, 2021, to February 7, 2024. The date of last follow-up was October 24, 2024. Intervention Patients were randomized 1:1 to proactive blood pressure management with mean arterial pressure targets based on risk of intraoperative hypotension (low risk, ≥70 mm Hg; intermediate risk, ≥80; high risk, ≥90) or usual management at their anesthesiologist's discretion, generally aiming to avoid a mean arterial pressure of less than 65 mm Hg without higher predefined targets. Main Outcomes and Measures The primary outcome was functional disability at 6 months, assessed with the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0; scale range, 0-100; higher scores indicate more disability). A minimally clinically important difference of 5 points was prespecified. There were 23 secondary outcomes, including quality of life, complications, and mortality within 6 months. Results The trial was stopped early for futility after 3247 of 5000 planned patients (median age, 59 years [IQR, 44-69]; 1738 female [53.5%]) were enrolled. A total of 677 patients (21%) were low risk; 1814 (56%), intermediate risk, and 756 (23%), high risk. Baseline median WHODAS scores were 12.5 [IQR, 4.2-29.2] in proactive group and 14.6 [IQR, 4.2-29.2] in standard group). At 6 months, mean (SD) WHODAS scores were 17.7 (20.1) in the proactive group and 18.2 (20.5) in the standard group (mean difference, -0.5; 95% credible interval, -1.9 to 0.9). There were no significant differences in any of the 23 secondary outcomes. Conclusions and Relevance Intraoperative blood pressure management with mean arterial pressure goals stratified by risk of hypotension did not improve functional disability at 6 months postoperatively compared with standard intraoperative blood pressure management. Trial Registration Overview of Medical Research in the Netherlands (CCMO): NL-OMON55117.
手术期间主动与被动治疗低血压:PRETREAT随机临床试验。
术中低血压与术后不良预后相关,但主动预防术中低血压是否能改善预后尚不确定。目的探讨与常规护理相比,术中按低血压风险分层的血压管理是否能减少接受非心脏手术的成人术后功能障碍。设计、环境和参与者在这项随机临床试验中,于2021年6月17日至2024年2月7日在荷兰的两家三级医院接受选择性非心脏手术的成年人入组。最后一次追踪的日期是2024年10月24日。干预:患者按1:1的比例随机分为主动血压管理组,根据术中低血压的风险(低风险,≥70 mm Hg;中风险,≥80;高风险,≥90)或由麻醉医师自行决定的常规血压管理组,一般旨在避免平均动脉压低于65 mm Hg,没有更高的预先设定目标。主要结局和测量指标:主要结局指标为6个月时的功能性残疾,采用世界卫生组织残疾评估表2.0 (WHODAS 2.0;量表范围0-100;分数越高表明残疾程度越严重)进行评估。预先规定了5分的最低临床重要差异。共有23个次要结局,包括6个月内的生活质量、并发症和死亡率。结果在计划入组的5000例患者(中位年龄59岁[IQR, 44-69岁],女性1738例[53.5%])中,有3247例患者因不孕而提前终止试验。低危患者677例(21%);1814人(56%)为中度风险,756人(23%)为高风险。基线WHODAS中位评分:主动组12.5 [IQR, 4.2-29.2],标准组14.6 [IQR, 4.2-29.2]。6个月时,主动组的平均(SD) WHODAS评分为17.7(20.1),标准组的平均(SD)评分为18.2(20.5)(平均差异为-0.5;95%可信区间为-1.9至0.9)。23项次要结果均无显著差异。结论及相关性:与标准的术中血压管理相比,按低血压风险分层的平均动脉压目标的术中血压管理并没有改善术后6个月的功能障碍。荷兰医学研究试验注册概述(CCMO): NL-OMON55117。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信